HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.

AuthorsIra D Galin, Donald A Smith
JournalAmerican heart journal (Am Heart J) Vol. 151 Issue 5 Pg. e1 (May 2006) ISSN: 1097-6744 [Electronic] United States
PMID16644302 (Publication Type: Letter, Comment)
Chemical References
  • Anticholesteremic Agents
  • Azetidines
  • Drug Combinations
  • Ezetimibe, Simvastatin Drug Combination
  • Heptanoic Acids
  • Pyrroles
  • C-Reactive Protein
  • Atorvastatin
  • Simvastatin
Topics
  • Anticholesteremic Agents (administration & dosage, therapeutic use)
  • Atorvastatin
  • Azetidines (administration & dosage, therapeutic use)
  • C-Reactive Protein (metabolism)
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Ezetimibe, Simvastatin Drug Combination
  • Heptanoic Acids (administration & dosage, therapeutic use)
  • Humans
  • Hypercholesterolemia (blood, drug therapy)
  • Pyrroles (administration & dosage, therapeutic use)
  • Simvastatin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: